Overall, for each antigen, we detected significant differences in the number of epitopes that could be used as components of a multiepitope malaria vaccine, with CelTOS and P36 having both CD4+ and CD8+ conserved T-cell epitopes. The gene discussed is CD8A; the disease is malaria.